Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CERE - Cerevel Therapeutics GAAP EPS of -$0.46

CERE - Cerevel Therapeutics GAAP EPS of -$0.46

Ceres Inc.
Cerevel Therapeutics press release (NASDAQ:CERE): Q1 GAAP EPS of -$0.46. Cash, cash equivalents and marketable securities of $550.9M are expected to continue to support operations into 2024. “Cerevel remains in an enviable position of strength as we seek to transform what is possible in neuroscience,” said Tony Coles, M.D., chairperson and chief executive officer of Cerevel Therapeutics. “We bring together the highest standard of clinical trial execution with the pipeline, the people, and the capital necessary to deliver new solutions for people living with vexing neuroscience diseases.”

For further details see:

Cerevel Therapeutics GAAP EPS of -$0.46
Stock Information
Company Name: Ceres Inc.
Stock Symbol: CERE
Market: NASDAQ
Website: cerevel.com
Menu
CERE CERE Quote CERE Short CERE News CERE Articles CERE Message Board
Get CERE Alerts

News, Short Squeeze, Breakout and More Instantly...